ZFIN ID: ZDB-FISH-150901-7885
Fish name: AB + MO1-oprm1
Genotype: AB
Targeting Reagent: MO1-oprm1
HUMAN DISEASE MODELED by AB + MO1-oprm1
No data available
GENE EXPRESSION
Gene expression in AB + MO1-oprm1
RNA expression
Expressed Gene Structure Conditions Figures
acox1 chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
bnip4 chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
camk1gb chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
copb2 chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
dao.1 chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
grb2b chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
magi1b chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
mir133b standard conditions Fig. 3 from Sanchez-Simon et al., 2010
oprm1 standard conditions Fig. 4 with image from Arévalo et al., 2018
otpb chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
pitx3 standard conditions Fig. 3 from Sanchez-Simon et al., 2010
plg chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
si:ch211-251b21.1 chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
slc6a3 standard conditions Fig. 3 from Sanchez-Simon et al., 2010
sox19b chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
th standard conditions Fig. 3 from Sanchez-Simon et al., 2010
wls chemical treatment: pharmaceutical Fig. 7 with image from Herrero-Turrión et al., 2014
standard conditions Fig. 7 with image from Herrero-Turrión et al., 2014
Reporter gene expression No data available
PHENOTYPE
Phenotype in AB + MO1-oprm1
Phenotype Conditions Figures
brain oprm1 expression decreased amount, abnormal standard conditions Fig. 4 with image from Arévalo et al., 2018
central nervous system oprm1 expression decreased amount, abnormal standard conditions Fig. 4 with image from Arévalo et al., 2018
whole organism Ab4-bdnf labeling decreased amount, abnormal chemical treatment by environment: morphine Fig. 4 from Jimenez-Gonzalez et al., 2016
whole organism Ab4-bdnf labeling decreased amount, abnormal control Fig. 4 from Jimenez-Gonzalez et al., 2016

CITATIONS  (5)